BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 33017574)

  • 1. Autotaxin inhibition reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction.
    Tripathi H; Al-Darraji A; Abo-Aly M; Peng H; Shokri E; Chelvarajan L; R Donahue R; Levitan BM; Gao E; Hernandez G; Morris AJ; Smyth SS; Abdel-Latif A
    J Mol Cell Cardiol; 2020 Dec; 149():95-114. PubMed ID: 33017574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autotaxin-LPA-LPP3 Axis in Energy Metabolism and Metabolic Disease.
    Jose A; Kienesberger PC
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice with targeted inactivation of ppap2b in endothelial and hematopoietic cells display enhanced vascular inflammation and permeability.
    Panchatcharam M; Salous AK; Brandon J; Miriyala S; Wheeler J; Patil P; Sunkara M; Morris AJ; Escalante-Alcalde D; Smyth SS
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):837-45. PubMed ID: 24504738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Autotaxin and Lysophosphatidic Acid Receptor 5 Attenuates Neuroinflammation in LPS-Activated BV-2 Microglia and a Mouse Endotoxemia Model.
    Joshi L; Plastira I; Bernhart E; Reicher H; Triebl A; Köfeler HC; Sattler W
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of the Lysophosphatidylcholine/Autotaxin/Lysophosphatidic Acid Axis in Acute-on-Chronic Liver Failure Is Associated With Mortality and Systemic Inflammation by Lysophosphatidic Acid-Dependent Monocyte Activation.
    Trovato FM; Zia R; Napoli S; Wolfer K; Huang X; Morgan PE; Husbyn H; Elgosbi M; Lucangeli M; Miquel R; Wilson I; Heaton ND; Heneghan MA; Auzinger G; Antoniades CG; Wendon JA; Patel VC; Coen M; Triantafyllou E; McPhail MJ
    Hepatology; 2021 Aug; 74(2):907-925. PubMed ID: 33908067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Autotaxin-Lysophosphatidic Acid Axis Promotes Lung Carcinogenesis.
    Magkrioti C; Oikonomou N; Kaffe E; Mouratis MA; Xylourgidis N; Barbayianni I; Megadoukas P; Harokopos V; Valavanis C; Chun J; Kosma A; Stathopoulos GT; Bouros E; Bouros D; Syrigos K; Aidinis V
    Cancer Res; 2018 Jul; 78(13):3634-3644. PubMed ID: 29724718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological Elevation of Circulating Bioactive Phosphosphingolipids Enhances Myocardial Recovery After Acute Infarction.
    Klyachkin YM; Nagareddy PR; Ye S; Wysoczynski M; Asfour A; Gao E; Sunkara M; Brandon JA; Annabathula R; Ponnapureddy R; Solanki M; Pervaiz ZH; Smyth SS; Ratajczak MZ; Morris AJ; Abdel-Latif A
    Stem Cells Transl Med; 2015 Nov; 4(11):1333-43. PubMed ID: 26371341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac-specific inactivation of LPP3 in mice leads to myocardial dysfunction and heart failure.
    Chandra M; Escalante-Alcalde D; Bhuiyan MS; Orr AW; Kevil C; Morris AJ; Nam H; Dominic P; McCarthy KJ; Miriyala S; Panchatcharam M
    Redox Biol; 2018 Apr; 14():261-271. PubMed ID: 28982073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signalling by lysophosphatidate and its health implications.
    Hemmings DG; Brindley DN
    Essays Biochem; 2020 Sep; 64(3):547-563. PubMed ID: 32451553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autotaxin Has a Negative Role in Systemic Inflammation.
    Nikitopoulou I; Katsifa A; Kanellopoulou P; Jahaj E; Vassiliou AG; Mastora Z; Dimopoulou I; Orfanos SE; Aidinis V; Kotanidou A
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of autotaxin expression and secretion by lysophosphatidate and sphingosine 1-phosphate.
    Benesch MG; Zhao YY; Curtis JM; McMullen TP; Brindley DN
    J Lipid Res; 2015 Jun; 56(6):1134-44. PubMed ID: 25896349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary Artery Disease Risk-Associated
    Mueller PA; Yang L; Ubele M; Mao G; Brandon J; Vandra J; Nichols TC; Escalante-Alcalde D; Morris AJ; Smyth SS
    Arterioscler Thromb Vasc Biol; 2019 Nov; 39(11):2261-2272. PubMed ID: 31533471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autotaxin determines colitis severity in mice and is secreted by B cells in the colon.
    Lin S; Haque A; Raeman R; Guo L; He P; Denning TL; El-Rayes B; Moolenaar WH; Yun CC
    FASEB J; 2019 Mar; 33(3):3623-3635. PubMed ID: 30481488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles for lysophosphatidic acid signaling in vascular development and disease.
    Smyth SS; Kraemer M; Yang L; Van Hoose P; Morris AJ
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Aug; 1865(8):158734. PubMed ID: 32376340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation.
    Gierse J; Thorarensen A; Beltey K; Bradshaw-Pierce E; Cortes-Burgos L; Hall T; Johnston A; Murphy M; Nemirovskiy O; Ogawa S; Pegg L; Pelc M; Prinsen M; Schnute M; Wendling J; Wene S; Weinberg R; Wittwer A; Zweifel B; Masferrer J
    J Pharmacol Exp Ther; 2010 Jul; 334(1):310-7. PubMed ID: 20392816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic targeting of the ATX/LPA axis attenuates bleomycin-induced pulmonary fibrosis.
    Ninou I; Kaffe E; Müller S; Budd DC; Stevenson CS; Ullmer C; Aidinis V
    Pulm Pharmacol Ther; 2018 Oct; 52():32-40. PubMed ID: 30201409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis.
    Tigyi GJ; Yue J; Norman DD; Szabo E; Balogh A; Balazs L; Zhao G; Lee SC
    Adv Biol Regul; 2019 Jan; 71():183-193. PubMed ID: 30243984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Bulk of Autotaxin Activity Is Dispensable for Adult Mouse Life.
    Katsifa A; Kaffe E; Nikolaidou-Katsaridou N; Economides AN; Newbigging S; McKerlie C; Aidinis V
    PLoS One; 2015; 10(11):e0143083. PubMed ID: 26569406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Expression Regulation and Biological Function of Autotaxin.
    Zhang X; Li M; Yin N; Zhang J
    Cells; 2021 Apr; 10(4):. PubMed ID: 33921676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of autotaxin/lysophospholipase d inhibitors.
    Federico L; Pamuklar Z; Smyth SS; Morris AJ
    Curr Drug Targets; 2008 Aug; 9(8):698-708. PubMed ID: 18691016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.